AgomAb Therapeutics

AgomAb Therapeutics is a Coöperatieve vennootschap in Antwerpen, Belgium with 1 ISIN-identified security mapped to its LEI, which is how regulators tie a traded instrument to the issuer behind it.

The LEI has been on record for 5 years, since 25 Mar 2021. That puts it right on the median for Belgium, where half of all LEIs date from before 2021.

The next annual re-validation is due 25 Mar 2027, 158 days from now.

The record has not changed since we began archiving it on 6 Jul 2026. Any future change to name, status, address, ownership or renewal date will be captured here, because GLEIF publishes only the current state and superseded values are otherwise lost.

The entity is registered with Crossroad Bank of Enterprises under registry number 0674527310, and the LEI itself is issued and maintained by EQS Group GmbH, one of the Local Operating Units accredited by GLEIF.

Beyond the LEI, 1 ISIN is mapped to this entity in the GLEIF cross-reference files.

No direct accounting-consolidating parent is reported, because its parent is one or more natural persons, who are outside the LEI system. GLEIF requires this to be stated explicitly rather than left blank, so the absence is itself a data point.

No ultimate accounting-consolidating parent is reported, because its parent is one or more natural persons, who are outside the LEI system. GLEIF requires this to be stated explicitly rather than left blank, so the absence is itself a data point.

The LEI registration is issued, and the entity status (active) records whether the legal entity itself still exists. The two are independent: an LEI can lapse while the company trades on, and it can stay issued after the company has been dissolved.